Kosaka, T., Shinojima, T., Morita, S., & Oya, M. (2018). Prognostic significance of grade 3/4 neutropenia in Japanese prostate cancer patients treated with cabazitaxel. Cancer Sci.
Styl ChicagoKosaka, Takeo, Toshiaki Shinojima, Shinya Morita, a Mototsugu Oya. "Prognostic Significance of Grade 3/4 Neutropenia in Japanese Prostate Cancer Patients Treated With Cabazitaxel." Cancer Sci 2018.
Citace podle MLAKosaka, Takeo, Toshiaki Shinojima, Shinya Morita, a Mototsugu Oya. "Prognostic Significance of Grade 3/4 Neutropenia in Japanese Prostate Cancer Patients Treated With Cabazitaxel." Cancer Sci 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..